$87.83▼ 1.22 (1.37%)
Real-time prices · US MarketsValuation metrics in line with sector peers.
weak profitability metrics drag quality score.
Quality
4.4
Health
5
Growth
5
Valuation
6.5
Sentiment
5
Analyst Target
—
Price Chart
Fundamentals
Trailing P/E
24.7×
price-to-earnings
Forward P/E
—
next 12 months est.
Market Cap
—
market capitalization
Div Yield
—
dividend yield
Profit Margin
—
net profit margin
Gross Margin
—
revenue minus COGS
ROE
—
return on equity
Beta
—
vs S&P 500
Price / Book
—
P/B ratio
52-Week Range
$66 — $124
annual min — max
Frequently Asked Questions
Is CURE a good stock to buy right now?
Direxion Daily Healthcare Bull 's Q·Score is 5.2/10 (Bearish), reflecting its current fundamentals, analyst data, and valuation metrics. Valuation metrics in line with sector peers. Key area to monitor: weak profitability metrics drag quality score. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
Is CURE overvalued or undervalued?
Direxion Daily Healthcare Bull (CURE) scores in line with sector averages on valuation metrics. Its trailing P/E ratio stands at 24.7×.